Mean (±SE) plasma concentrations of soluble TNF- receptor I and II after intravenous injection of LPS in subjects receiving either GI5402 (□) or placebo (•) 20 minutes before LPS challenge (lot G, 4 ng/kg). P value indicates the difference between treatment groups.